The global capsule endoscopy market is estimated to be valued at over US$ 1.1 billion by the end of 2033 and is projected to grow at a CAGR of over 8.6% during the forecast period from 2025 to 2033.
Capsule endoscopy (CE) is a procedure that utilizes a minuscule, bug-sized camera for capturing images of the digestive tract. The camera is placed in a minuscule capsule that is swallowed. The capsule advances through the digestive tract, alongside the camera, capturing numerous images that are transferred to a recorder located on the waist. It allows the doctor to examine the inside of the small intestine. The small intestine area isn’t accessible with traditional endoscopy procedures. Capsule endoscopy is beneficial in situations where a doctor needs to diagnose swelling, bowel disease, and cancer. Doctors use capsule endoscopy to find the source of gastrointestinal bleeding. According to industrial experts, capsule endoscopy is more productive and preferred over X-rays of barium for the treatment of Gastrointestinal bleeding. The market is divided into esophageal, colon, and small bowel capsules. Small bowel capsules account for the majority of the market share.
Vast advancements in technology are making capsule endoscopy a more familiar procedure. It has created a huge opportunity for manufacturers and led to the inclusion of capsule endoscopy in national & international guidelines. The government's initiatives and rising demand for quick and accurate diagnostic tools have further fuelled the market. In 2018, the Australian government 2018 reduced the fee for capsule endoscopy. Additionally, in 2013, the Canadian administration launched a project in Bangladesh aimed at developing economical and affordable devices to detect gastrointestinal bleeding. Capsule endoscopy has been a major technological innovation in recent times, driven by the high demand for primary diagnosis and management of bowel diseases. The rapid advancement of technologies led to a paradigm shift in the progression of broadening indications in clinical applications. It is an invaluable asset for clinical practice and outperforms other investigational modalities. Additionally, the increasing prevalence of gastric disorders increased the traction during the forecast period. However, the absence of skilled professionals, combined with the high cost of advanced technologies, has restrained the market's growth.
Capsule Endoscopy Market Restraint:
• Absence of skilled professionals
• Expensive cost of advanced technologies
Capsule Endoscopy Market Segmentation
By Component
- Capsule Endoscope
- Capsule Endoscopy Data Recorder
- Capsule Endoscopy Workstation
By Endoscope Type
- Capsule Cystoscopies
- Capsule Neuro-Endoscopes
By Product
- Small Bowel Capsule
- Esophageal Capsule
- Colon Capsule
By Application
- Obscure Gastrointestinal Bleeding (OGIB)
- Crohn’s Disease
- Small Intestine Tumor
By End User
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
North America: Holding the largest market share, North America's dominance is attributed to the early adoption of advanced medical technologies, well-established healthcare infrastructure, and favorable reimbursement policies. The region's focus on minimally invasive procedures has further propelled the demand for capsule endoscopy.
Europe: Europe follows closely, with significant contributions from countries like Germany, France, and the UK. The region's emphasis on early disease detection and preventive healthcare measures supports the growth of capsule endoscopy utilization.
Asia-Pacific: Anticipated to witness the highest growth rate, the Asia-Pacific region's expanding healthcare infrastructure, increasing awareness of advanced diagnostic technologies, and rising prevalence of gastrointestinal diseases drive market expansion. Countries such as China and India are at the forefront of this growth.
Major players included in the Capsule Endoscopy Market:
- Olympus Corporation
- RF Co. Ltd.
- IntroMedic Co., Ltd.
- AccuRead Endoscopy Inc.
- Boston Scientific Corporation
- Medtronic Plc
- CapsoVision, Inc.
- Northside Gastroenterology Endoscopy Center, LLC
- Chongqing Jinshan Science and Technology Co.
- Interscope Inc.
- Given Imaging Ltd.
Recent Developments by Leading Companies
Medtronic: In March 2024, Medtronic introduced the PillCam™ SB4 system, featuring enhanced imaging capabilities and improved battery life. Additionally, the company has incorporated AI algorithms in their capsule endoscopes, enhancing the speed and accuracy of diagnosis.
Olympus Corporation: In February 2024, Olympus unveiled its next-generation capsule endoscopy platform, incorporating AI-powered lesion detection algorithms. The company also partnered with Hitachi Ltd. to develop endoscopic ultrasound systems (EUS) for early patient diagnosis, reflecting a collaborative effort to advance innovative technologies in the field.
CapsoVision: CapsoVision has collaborated with major hospitals and gastroenterology clinics to introduce its CapsoCam Plus, which features a 360-degree panoramic view of the gastrointestinal tract. By working closely with healthcare providers, the company trains clinicians, supports clinical trials, and ensures seamless technology adoption.
Objectives of the Study:
• To provide an exhaustive analysis on the global Capsule Endoscopy Market By component, By endoscope type, By product, By application, By end user, and By Region
• To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record, evaluate, and create a competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com